Bilateral breast carcinoma after radiation therapy for Hodgkin's disease.
The success of modern cancer therapy is resulting in an increasing number of long-term cures. The price of success, however, is the incidence of treatment-related morbidity and mortality. The physician should be aware of the potential sequelae of cancer therapy. A case of bilateral breast cancer occurring 13 years after radiation therapy for Hodgkin's disease prompted me to examine the incidence of this problem and to make recommendations for surveillance of patients.
Colvett
K T
KT
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston 02114.
D000293:Adolescent; D000328:Adult; D001943:Breast Neoplasms / Q000209:etiology*; D002278:Carcinoma in Situ / Q000209:etiology*; D018270:Carcinoma, Ductal, Breast / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000532:radiotherapy*; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D016609:Neoplasms, Second Primary / Q000209:etiology*; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy / Q000009:adverse effects